NAMSA and InspireMD Announce Strategic Outsourcing Partnership to Accelerate New Product Development
TOLEDO, Ohio & TEL AVIV, Israel–(BUSINESS WIRE)–#CRO—NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, and InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for treatment of carotid artery disease and prevention of stroke, announced today that they have entered into a strategic outsourcing partnership to accelerate … [Read more…]
